Prophylactic surgery rates among men with breast cancer nearly double
the ONA take:
The rates of contralateral prophylactic mastectomy (CPM) among men with breast nearly doubled between 2004 and 2011, which mirrors a trend seen in women with breast cancer, according to a report from American Cancer Society and Dana Farber Cancer Institute researchers.
In women, particularly younger women, use of CPM has increased over the past two decades despite a lack of evidence for survival benefit, associated costs, and possible complications. Breast cancer in men accounts for approximately 1% of all cases in the United States.
The researchers pulled nationwide data from the North American Association of Central Cancer Registries on 6,332 men who underwent surgery for breast cancer limited to one breast between 2004 and 2011.
Rate of CMP among men increased from 3.0% in 2004 to 5.6% in 2011. The sociodemographic factors linked to more surgery in men were similar to those for women who underwent CPM: being white, younger age, and having private insurance.
However, the study did not have data on other factors linked to women who choose to undergo CPM, such as genetic testing, family history, magnetic resonance imaging, or fear of breast cancer occurring in the other breast.
The rates of contralateral prophylactic mastectomy (CPM) among men with breast nearly doubled between 2004 and 2011.
Sign Up for Free e-newsletters
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Breast Implants Associated With Increased Risk of Breast Anaplastic Large-cell Lymphoma
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
- OS Similar With Gemcitabine Plus S-1 vs Standard Therapy for Biliary Tract Cancer
- Feasibility and Outcomes of Modified Enhanced Recovery After Surgery for Nursing Management of Aged Patients Undergoing Esophagectomy
- Urine Drug Testing Policy Can Assist Opioid Treatment Decisions
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|